Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Keiichi, Kontani"'
Autor:
Yoko Matsuda, Juanjuan Ye, Keiko Yamakawa, Yuri Mukai, Kazuki Azuma, Linxuan Wu, Kenkichi Masutomi, Taro Yamashita, Yataro Daigo, Yohei Miyagi, Tomoyuki Yokose, Takashi Oshima, Hiroyuki Ito, Soichiro Morinaga, Takeshi Kishida, Toshinari Minamoto, Motohiro Kojima, Shuichi Kaneko, Reiji Haba, Keiichi Kontani, Nobuhiro Kanaji, Keiichi Okano, Mariko Muto-Ishizuka, Masanao Yokohira, Kousuke Saoo, Katsumi Imaida, Futoshi Suizu
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:208-218
Background Telomere dysfunction has been reported to be directly involved in carcinogenesis owing to chromosomal instability and immortalization; however, the clinicopathological significance of telomeres remains controversial. We have shown that tel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706f64ebf2c22002eac0be69013c7228
https://doi.org/10.1093/jnci/djac226
https://doi.org/10.1093/jnci/djac226
Autor:
Kazumasa Ogasawara, Keiichi Kontani, Shozo Fujino, Tohru Asai, Yasushi Itoh, Noriaki Tezuka, Jun Hanaoka, Yoshitomo Ozaki, Koji Teramoto, Takuya Fujita
Supplementary Figure 1 from Inhibition of Transforming Growth Factor-β–Mediated Immunosuppression in Tumor-Draining Lymph Nodes Augments Antitumor Responses by Various Immunologic Cell Types
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19e18f5157bba48c443ae8d7a79d6c02
https://doi.org/10.1158/0008-5472.22377711
https://doi.org/10.1158/0008-5472.22377711
Autor:
Kazumasa Ogasawara, Keiichi Kontani, Shozo Fujino, Tohru Asai, Yasushi Itoh, Noriaki Tezuka, Jun Hanaoka, Yoshitomo Ozaki, Koji Teramoto, Takuya Fujita
Supplementary Figure 2 from Inhibition of Transforming Growth Factor-β–Mediated Immunosuppression in Tumor-Draining Lymph Nodes Augments Antitumor Responses by Various Immunologic Cell Types
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443d668c56553da168301d9af79f4e75
https://doi.org/10.1158/0008-5472.22377708.v1
https://doi.org/10.1158/0008-5472.22377708.v1
Autor:
Chisa Murazawa, Nozomi Hashimoto, Kana Kuraishi, Mutsumi Motoyama, Shin-Ichiro Hashimoto, Mayumi Ikeuchi, Shoko Norimura, Toru Matsunaga, Koji Teramoto, Reiji Haba, Noriko Abe, Toshiki Yajima, Keiichi Kontani
Publikováno v:
Oncology Letters. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e85ac5c8ab435fb737ea68fd624f7f3
https://doi.org/10.3892/ol.2023.13750
https://doi.org/10.3892/ol.2023.13750
Autor:
Keiichi Kontani1 konbat@med.kagawa-u.ac.jp, Kana Kuraishi1, Shin-ichiro Hashimoto1, Shoko Norimura2, Nozomi Hashimoto1, Masahiro Ohtani3, Naomi Fujiwara-Honjo4, Manabu Date5, Koji Teramoto6, Hiroyasu Yokomise1
Publikováno v:
Oncologie (Tech Science Press). 2021, Vol. 23 Issue 2, p229-239. 11p.
Autor:
Koji Teramoto, Yoshitomo Ozaki, Jun Hanaoka, Satoru Sawai, Noriaki Tezuka, Shozo Fujino, Yataro Daigo, Keiichi Kontani
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Background: The dendritic cell (DC)-based vaccine targeting the highly immunogenic tumor antigen, MUC1, has been promising for a cancer immunotherapy; however, predictive biomarkers for beneficial clinical responses of the vaccine remain to be determ
Externí odkaz:
https://doaj.org/article/66b8d1d2a1e2416098770ab12587ce18
Autor:
Koji Teramoto, Hiroyasu Yokomise, Shinichiro Hashimoto, Shoko Norimura, Naomi Fujiwara-Honjo, Nozomi Hashimoto, Kana Kuraishi, Manabu Date, Masahiro Ohtani, Keiichi Kontani
Publikováno v:
Oncologie. 23:229-239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::648358965640d55fda7b32bf302b542c
https://doi.org/10.32604/oncologie.2021.016277
https://doi.org/10.32604/oncologie.2021.016277
Autor:
Yoko Matsuda, Taro Yamashita, Juanjuan Ye, Mami Yasukawa, Keiko Yamakawa, Yuri Mukai, Mitsuhiro Machitani, Yataro Daigo, Yohei Miyagi, Tomoyuki Yokose, Takashi Oshima, Hiroyuki Ito, Soichiro Morinaga, Takeshi Kishida, Toshinari Minamoto, Shinji Yamada, Junko Takei, Mika K Kaneko, Motohiro Kojima, Shuichi Kaneko, Tsutomu Masaki, Masahiro Hirata, Reiji Haba, Keiichi Kontani, Nobuhiro Kanaji, Nobuyuki Miyatake, Keiichi Okano, Yukinari Kato, Kenkichi Masutomi
Publikováno v:
The Journal of pathology. 257(2)
Recent evidence indicates that RNA-dependent RNA polymerase (RdRP) activity of human telomerase reverse transcriptase (hTERT) regulates expression of target genes and is directly involved in tumor formation in a telomere-independent manner. Non-canon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4f7dcfd7d0bcf5227fa6a835832cc
https://pubmed.ncbi.nlm.nih.gov/35094384
https://pubmed.ncbi.nlm.nih.gov/35094384
Autor:
Akimitsu Yamada, Kazutoshi Shibuya, Masataka Sawaki, Eiichi Sasaki, Tetuo Mikami, Hideaki Ogata, Keiichi Kontani, Tomio Arai, Naoko Honma, Mika Miyashita, Yoko Matsuda
Publikováno v:
Human pathology. 111
Triple-negative breast cancer (TNBC) lacks an effective treatment target and is usually treated with chemotherapy. Treatment of older patients with TNBC, however, should be decided carefully because of the side effects of chemotherapy in this populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c995809910ae22e15e15198f0dd747
https://pubmed.ncbi.nlm.nih.gov/33548251
https://pubmed.ncbi.nlm.nih.gov/33548251
Autor:
Hiroyasu Yokomise, Kazunori Yamaguchi, Keiichi Kontani, Takahiro Motoki, Hiroaki Tanaka, Hitoshi Houchi, Koichi Takahashi, Shinji Kosaka, Masato Asakura
Publikováno v:
Biological and Pharmaceutical Bulletin. 41:644-648
Bevacizumab (BV), an inhibitor of vascular endothelial growth factor, is used in combination with paclitaxel (PTX) to treat advanced breast cancer. Hypertension and proteinuria are characteristic adverse events of BV therapy. We assessed the potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3020b7c5045975778c62756a0f40746
https://doi.org/10.1248/bpb.b17-00605
https://doi.org/10.1248/bpb.b17-00605